Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: Methodological issues of a randomized controlled trial

Authors

Oluwakemi B. Badaki-Makun, George Washington University
J. Paul Scott
Julie A. Panepinto
T. Charles Casper
Cheryl A. Hillery
J. Michael Dean
David C. Brousseau
+15 additional collaborators

Document Type

Journal Article

Publication Date

6-2014

Journal

Pediatric Blood and Cancer

Volume

Volume 61, Issue 6

Inclusive Pages

1049-1054

Keywords

Anemia, Sickle Cell--complications; Anti-Inflammatory Agents--therapeutic use; Arterial Occlusive Diseases--drug therapy; Interdisciplinary Communication; Magnesium Sulfate--therapeutic use; Multicenter Studies as Topic--methods; Randomized Controlled Trials as Topic--methods; Vasodilator Agents--therapeutic use

APA Citation

Badaki-Makun, O., Scott, J.P., Panepinto, J.A., Casper, T.C., Hillery, C.A. et al. (2014). Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. Pediatric Blood and Cancer, 61(6), 1049-1054.

Peer Reviewed

1